Inflammation and melanoma metastasis

Vladislava O. Melnikova, Menashe Bar-Eli

Research output: Contribution to journalReview articlepeer-review

78 Scopus citations

Abstract

Metastatic melanoma is extremely refractory to existing chemotherapeutic drugs and bioimmune adjuvant therapies, and the life span of patients with metastatic melanoma is often measured in months. Understanding the mechanisms responsible for the development of tumor metastasis is critical for finding successful curative measures. An expending amount of data reveal the importance of inflammatory microenvironment and stroma in cancer initiation and progression, which brings new directions and approaches to cancer treatment. This review will summarize current data on the role of the tumor microenvironment in shaping the metastatic phenotype of melanoma.

Original languageEnglish (US)
Pages (from-to)257-267
Number of pages11
JournalPigment Cell and Melanoma Research
Volume22
Issue number3
DOIs
StatePublished - Jun 2009

Keywords

  • Melanoma
  • Metastasis
  • Microenvironment
  • PAR1
  • Platelet-activating factor
  • Platelets
  • Thrombin receptor
  • Tumor

ASJC Scopus subject areas

  • Oncology
  • General Biochemistry, Genetics and Molecular Biology
  • Dermatology

Fingerprint

Dive into the research topics of 'Inflammation and melanoma metastasis'. Together they form a unique fingerprint.

Cite this